Opinion · United States Court of Appeals for the Federal Circuit

IN RE CYCLOBENZAPRINE HYDROCHLORIDE, 424 Fed.Appx. 952 (Fed. Cir. 2011)

424 Fed.Appx. 952

Type
Opinion
Court
United States Court of Appeals for the Federal Circuit
Jurisdiction
Federal
Date
2011-05-25
Topic
general

IN RE CYCLOBENZAPRINE HYDROCHLORIDE, 424 Fed.Appx. 952 (Fed. Cir. 2011) In re CYCLOBENZAPRINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULE PATENTLITIGATION. Eurand, Inc., Cephalon, Inc., and Anesta AG,Plaintiffs-Appellees, v. Mylan Pharmaceuticals Inc. and Mylan Inc.,Defendants-Appellants. No. 2011-1399.United States Court of Appeals, Federal Circuit.

Citator

UpLaw has not yet analyzed IN RE CYCLOBENZAPRINE HYDROCHLORIDE, 424 Fed.Appx. 952 (Fed. Cir. 2011). The absence of a flag is not a finding that it is good law.